Digital Access

Digital Access
Access theherald-news.com and all Shaw Media Illinois content from all your digital devices and receive breaking news and updates from around the area.

Home Delivery

Home Delivery
Local news, sports, business, classified and more! News you can use every day.

Text Alerts

Text Alerts
Choose your news! Select the text alerts you want to receive: breaking news, weather, and more.

Email Newsletters

Email Newsletters
Have our latest news, sports and obituaries emailed directly to you Monday through Friday so you can keep up with what's happening in the area.
Coronavirus

WHO: 17 coronavirus vaccine candidates are in human trials

Several vaccines are expected to move into large-scale trials to provide important data

People wearing masks to curb the spread of the new coronavirus wait for businesses to open in downtown Lima, Peru, Wednesday, July 1, 2020. (AP Photo/Martin Mejia)
People wearing masks to curb the spread of the new coronavirus wait for businesses to open in downtown Lima, Peru, Wednesday, July 1, 2020. (AP Photo/Martin Mejia)

As a public service, Shaw Media will provide open access to information related to the COVID-19 (Coronavirus) emergency. Sign up for the newsletter here

LONDON — The World Health Organization says the world is “lucky” there is a broad pipeline of experimental COVID-19 vaccines, with more than 150 at early stages of testing.

At the end of a two-day research meeting, the U.N. health agency says 17 vaccine candidates are in human trials and some might prove effective by the end of the year, although that the timeline of a licensed vaccine was still uncertain.

“We are very encouraged by the progression of these candidate vaccines and we are looking forward to have the results,” said Ana Maria Henao Restrapo, a vaccines expert at WHO.

She says the pharmaceuticals planning advanced tests in humans shared their protocols for proposed trials with the agency; all were randomized experiments. Several experimental vaccines, including one developed by Oxford University and made by AstraZeneca, are expected to soon move into large-scale trials that could provide data about whether they are effective.

“Whether or not we will have a vaccine in the anticipated timeline is still unknown,” Restrapo said.

Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Loading more